Device China DeviceChina - Home 中文版 zhuce showcase Frequently Asked Questions 主页 English Language 注册参会 路演报名 疑问解答


If you are interested in becoming an event partner for DEVICECHINA 2019, please contact Mingyuan Sui at

2019 Partners


Innovation Service Committee of China Medical Device Industry Association

With the foundation of "innovation services, transformation of medicine and science and technology finance" as the main line of services, the Committee convergence and expansion of various innovative elements and resources in virous industries to provide full-service to the d medical equipment innovation companies. By providing Product design outsourcing, animal and clinical trials, product registration and patent applications, commissioned production, upstream spare parts integrated procurement services, domestic and foreign market channel docking, academic exchange and exhibitions, and other premier professional services, as well as Product strategic planning, transformation of scientific and technological achievements, innovative project research, national funding applications, the park site selection and production line import, corporate finance listing and mergers and acquisitions, setting up overseas enterprises and other upgrading services through both online & offline to enhance the overall development of medical equipment industry.

Suzhou Yingnuomai Medical Innovation Service

As Member of National Medical Device Industry Technology Innovation Service Alliance, is authorized by the National Medical Device Industry Technology Innovation Service Alliance professional to operate the web site

We provide 15 one-stop innovation services like Innovative project pre-research, product design, National and local funding applications, Animal experiments and third-party testing, Clinical Trials, Domestic and foreign registration services, Domestic and foreign patent applications, Production business, Upstream material device procurement, Policies and regulations advice, Achievement Transformation and Transformation Medical Services , Project valuation and financing, Overseas projects to entering Chinese service, Innovative training and conference.

Supporting Partners

BayHelix Group

BayHelix Group is a non-profit, invitation-only organization of business leaders of Chinese heritage that fosters the growth of the life sciences and healthcare industry around the Pacific Rim and beyond. Founded in 2001, BayHelix has grown to over 300 members throughout the U.S., Canada, and Greater China. The membership base covers virtually all of the world’s top pharmaceutical and biopharmaceutical companies, as well as leading services and investment firms. Over one third of the members are senior executives, over 80% have PhDs in the life sciences, and nearly half have MBAs from the leading business schools in U.S.


Since 1993, BioCentury Publications, Inc. has been internationally recognized as the leading provider of value-added information, analysis and data for biotechnology and pharmaceutical companies, investors, academia and government on the strategic issues essential to the formation, development and sustainability of life science ventures.

ChinaBio® LLC

Since its founding in January, 2007, ChinaBio® LLC has rapidly launched a number of initiatives accelerating the globalization of China's life science industry. ChinaBio has helped China companies raise nearly $400 million and global life science companies identify over 400 licensing and acquisition opportunities in China.

  • Conferences: ChinaBio organizes the premier life science investment and partnering conferences in China, having attracted over 4,000 attendees.
  • Consulting: ChinaBio works with global life science companies and China entrepreneurs to define and execute a successful global strategy.
  • Transactions: ChinaBio Capital helps companies secure partnerships and acquisitions and access private and government funding in China.
  • Publishing: ChinaBio Today is the most widely read online and email newsletter on China's life science industry.


“Xieyi” is one of traditional Chinese painting expression form known for composition simple yet rich implications. Compared with realistic style of painting, Xieyi is more natural and unrestrained, but conveys excellently unique artistic charm. In the medical field, there is a group of new drug elites which often gather together to exchange their ideas freely about new drug technology, technology management and their career. They have freed themselves from their old collective image of stiffness (as claborate-style painting) and now take part in the new drug development field with their truest and freest nature.

Media Partners


Biodiscover ( is a newly media portal to explore the value of biosciences, and committed to disseminate the forefront of biotechnology and successful business model in the field of life sciences.

Our website introduces the most advanced and dynamic bioinformatics technology in the field of life sciences, providing prospective, in-depth research information and technical topics for biologists in china; providing the latest bioindustry dynamics and reports for enterprises; providing a interaction platform for biological enterprises and individuals; integrating the latest exhibitions, conferences and technical seminars of biopharmaceutical etc.


BioonGroup was established since 2001. Now it has become the leading media platform and professional service provider of Bio-medicine industry. Multi service can be provided in consulting, industry analysis, brand packaging, product promotion, human resources, conference planning and medical research service for enterprises, R&D, universities, parks and the government of Bio-medicine industry. BioonGroup contains six well-known platforms (,,,,, ) and three professional institutions (MedSci, BioInsight, Bioon|Events ).


创业邦创立于2007年1月,由美国国际数据集团(IDG)和清科集团共同投资设立。创 业邦以“创新成长、创业兴邦”为使命,旗下拥有《创业邦》杂志、创业邦网站、创 业邦活动以及创业邦天使投资等全线业务。创业邦网站(是中国创业者的 资讯门户和互动平台,致力于成为中国创业者的网上家园。《创业邦》杂志致力于成 为中国创业者的思想乐园和行动指南,为中国成长中的中小企业提供企业发展中遇到 的各种问题的解决办法。创业邦还定期举办创业沙龙、项目展示等活动,鼎力打造线下互动交流平台,帮助创业者建立、积累和丰富商业伙伴网络和资源。


DXY ( was established in July 23, 2000, and it has been committed to be a online platform for the broad masses of medical, pharmaceutical, life science professionals since its inception. With the accumulation of expertise and information sharing, the DXY gradually grow into the largest and the most famous website in the area of the bio-medical industry in China. Actually, it is worth mentioning that DXY adhered to the spirit of “professionalism, independence and nonprofit”.

Now, The DXY covers about 2.7 million medical, pharmaceutical and life sciences professionals. In addition to the online community, The DXY also takes up four subsidiary websites,,, and, which provide job recruitment , B2B2C business respectively.


GBI is China’s leader in data intelligence and consulting services for China’s pharmaceutical, biotechnology and healthcare industries. Our suite of Enterprise Products offers unparalleled data intelligence services for pharma & device management, SFE, sales & marketing, life science researchers as well as healthcare legal professionals; GBI provides in-depth analysis and insights into the competitive landscape healthcare actors need in order to capitalize on the tremendous opportunities available in China. Our clients include most multinational pharmaceutical companies and a leading group of biotechnology companies, healthcare companies, investors, consultants, law firms and financial analysts.

Healthcare Executive

Healthcare Executive (“HE”) is a monthly journal published by ZhuoXin Medical Media Group (ZXMMG) since December 2008, under the auspices of the China Pharmaceutical Enterprises Management Association (CPEMA).

HE offers the most comprehensive news and information source for decision makers and managers in the medical and pharmaceutical industry in China. HE covers the latest news and developments in the healthcare sector, descriptions of new product developments, R&D trends, pharmaceutical production and distribution, and a full analysis of changing regulatory and policy landscape in China.

PEDaily is a leading web portal in the venture capital and private equity industry in China. Inte- grating the strongest networks and research resources of Zero2IPO Group, focuses on sharing timely industry news, abundant data, and in-depth analysis with its users., the leading health portal in China, was launched on March 9, 2000. is committed to use the Internet as a platform to deliver specific health information and disseminate new health concepts. In 2014, won the first Chinese health website access to the capital markets.